Avantor (NYSE:AVTR) Announces Earnings Results, Beats Expectations By $0.02 EPS

Avantor (NYSE:AVTR) released its quarterly earnings results on Friday. The company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.20 by $0.02, Briefing.com reports. Avantor had a return on equity of 14.11% and a net margin of 4.61%. The firm had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the firm posted $0.29 EPS. The business’s revenue was down 5.6% on a year-over-year basis.

Avantor Stock Performance

AVTR stock traded down $1.21 during midday trading on Friday, hitting $23.94. The company’s stock had a trading volume of 14,185,165 shares, compared to its average volume of 4,145,237. The stock’s 50-day moving average price is $25.08 and its 200 day moving average price is $22.61. The company has a quick ratio of 1.05, a current ratio of 1.61 and a debt-to-equity ratio of 1.00. Avantor has a 1 year low of $16.63 and a 1 year high of $26.16. The stock has a market cap of $16.24 billion, a price-to-earnings ratio of 49.88, a PEG ratio of 2.56 and a beta of 1.37.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on AVTR shares. JPMorgan Chase & Co. upped their price target on Avantor from $26.00 to $29.00 and gave the stock an “overweight” rating in a research report on Thursday, February 15th. Citigroup increased their price objective on Avantor from $24.00 to $30.00 and gave the company a “buy” rating in a report on Thursday, February 15th. Robert W. Baird raised their price target on Avantor from $25.00 to $26.00 and gave the company an “outperform” rating in a report on Thursday, February 15th. UBS Group raised their price target on Avantor from $25.00 to $29.00 and gave the company a “buy” rating in a report on Thursday, February 15th. Finally, Evercore ISI raised their price target on Avantor from $26.00 to $28.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat, Avantor presently has a consensus rating of “Moderate Buy” and a consensus price target of $26.71.

Insiders Place Their Bets

In other Avantor news, EVP James Bramwell sold 6,203 shares of the business’s stock in a transaction on Tuesday, February 27th. The stock was sold at an average price of $24.49, for a total value of $151,911.47. Following the transaction, the executive vice president now owns 101,143 shares of the company’s stock, valued at $2,476,992.07. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 1.50% of the company’s stock.

About Avantor

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.